
|Articles|November 15, 2003
FDA panel recommends OK for STAAR's ICL
Monrovia, CA-The FDA's Ophthalmic Devices Panel of the Center for Devices and Radiological Health is recommending that STAAR Surgical Co.'s Implantable Contact Lens (ICL) be approved with conditions for use in correcting ?3 to ?15 D of myopia and reducing myopia in the range of ?15 to ?20 D.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
From bench to bedside: Evolving realities of gene therapy for inherited retinal diseases
2
8 things to know about aflibercept 8 mg for retinal vascular disease
3
Topical liposomal ozonated oil may be a useful treatment in neurotrophic keratopathy
4
Seeing the difference: Multimodal imaging for AMD and GA
5







































